Endo International PLC (NASDAQ:ENDP)

9.39
BATS BZX Real-Time Price
As of 10:04am ET
 +0.09 / +0.97%
Today’s Change
5.27
Today|||52-Week Range
12.54
+21.16%
Year-to-Date
Francis Chou's Valeant Hits Almost 2-Year High
Jun 15 / GuruFocus News - Paid Partner Content
BioMarin Begins Pediatric Study on Achondroplasia Candidate
Jun 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close9.30
Today’s open9.36
Day’s range9.33 - 9.49
Volume44,047
Average volume (3 months)5,801,337
Market cap$1.4B
Data as of 10:04am ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+39.32%
Earnings growth (this year)-38.10%
Earnings growth (next 5 years)-11.20%
Revenue growth (last year)-13.50%
P/E ratioNM
Price/Sales0.50
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-1.30-1.93%
AXONAxovant Sciences Ltd-0.07-2.62%
HZNPHorizon Pharma PLC-0.07-0.40%
CORTCorcept Therapeutics...-0.01-0.06%
Data as of 10:05am ET, 06/22/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$0.54
Annual revenue (last year)$3.5B
Annual profit (last year)-$2.0B
Net profit margin-35.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts